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Abstract The aim of this study was to assess the
frequency and the outcome of patients suffering from
rheumatoid arthritis in which calcium pyrophosphate
dihydrate (CPPD) crystal deposits were found to coexist
in synovial fluid analysis. Such association was more
frequent than previously believed with CPPD crystals
found in 25.8% of 93 patients with rheumatoid arthritis. As
a group, a trend toward a worse outcome was suggested by
more frequent prostheses of the lower limb.
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Introduction
In osteoarthritis (OA), severe joint lesions were observed
more frequently in cases in which pyrophosphate arthrop-
athy coexists [1]. It has also been shown that calcium
pyrophosphate dihydrate (CPPD) crystal deposition dis-
ease is present in about 20% of patients suffering from OA
[2].
By contrast, CPPD crystal deposition disease has been
considered to be very rare in rheumatoid arthritis (RA) [3].
As secondary OA may be superimposed to an old
rheumatoid damage, it appeared interesting to determine
the frequency with which CPPD crystal deposits were
found in synovial fluid (SF) of RA patients and to compare
the clinical outcome of RA patients with and without
CPPD crystals in the SF.
Patients and methods
In a retrospective study, we reviewed the results of SFs of
93 cases of RA. All had a classical RA according to the
ACR classification criteria [4], and 76% of them were
rheumatoid factor positive. Synovial fluids were system-
atically examined for the presence of crystals. CPPD
crystal deposition disease was diagnosed when typical
rod-shaped, slightly positive birefringent crystals were
observed under compensated polarised light at 40× mag-
nification after centrifugation of SF. The presence of
radiological signs of CPPD crystal deposition (chondro-
calcinosis) was not mandatory to diagnosis and was not
systematically recorded. In most cases, SF was obtained
from knee joints. SF analysis included leucocyte count
with a differential. Apatite crystals were not searched
routinely. Demographic data of patients with and without
CPPD crystal deposits in SF were compared. The number
of lower limb joint prostheses was recorded at the time of
SF sampling.
Results
Of the 93 RA cases, 64 were females (69%). The mean age
was 64.5 years (limits 23–89 years). CPPD crystal deposits
were observed in SF in 24 of the 93 cases (25.8%). Table 1
shows comparisons of duration of disease and number of
prostheses of lower limbs for both groups. Duration of
disease was quite long with a mean superior to 12 years, but
with no statistically significant difference between both
groups. Percentage of cases with a prosthesis was higher in
the group with associated CPPD deposits (37.5 vs 21.7%),
representing an odd ratio of 2.2. Figure 1 illustrates one of
the cases.
Discussion
Associated CPPD crystal deposition disease has been con-
sidered to be very rare in RA [3]. We found, by a systematic
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analysis of SF, that the prevalence of pyrophosphate
crystals in RA knee joints is much higher than previously
suspected. Previous studies on the incidence of pyrophos-
phate arthropathy associated to RA have been made mainly
on the basis of radiographs, which could explain why the
incidence was much lower than in our series [5]. Radio-
graphic diagnosis of a superimposed chondrocalcinosis can
be quite difficult in advanced RA. Finally, the use of
centrifuged SF specimens, a technique that certainly
improves the detection of CPPD crystals, could also
explain this apparent discrepancy. Whether centrifugation
was systematically performed in the other studies was not
mentioned [6].
The fact that most SF were from knee joints may
introduce a bias in our study. CPPD crystal deposits were
found frequently in this RA population. Median RA
duration of disease was superior to 12 years, and CPPD
crystal deposits may just reflect accumulating joint damage
overtime. It is well known that localized trauma predis-
poses to dystrophic limited chondrocalcinosis, a phenom-
enon that could explains part of our high prevalence.
However, presence of CPPD crystal deposits was
demonstrated in more than 25% of those SF, and they
could also be a marker of a more severe outcome as
suggested by a trend toward a higher number of prostheses
in RA patients with coexistent crystals in SF. Calcium
crystal deposits (CPPD or apatite) can be found in about
60% of patient with OA in a preoperative knee [7], and
their role as innocent bystander or culprit is still debated.
In RA patients, the question also remains and will not be
answered by our study. However, the observed higher
incidence of prostheses despite a not significantly different
disease duration suggests that demonstration of CPPD
crystals in SF of a RA joint can be regarded as predictive
factor of impending joint destruction and surgery need.
Further studies will be needed to define if CPPD crystals
have any causative role in this ominous evolution.
Take home message
. CPPD crystals are found in a fourth of SF from long-
standing RA patients, a percentage much more fre-
quent than previously thought.
. Coexisting CPPD crystals in SF of RA patients is
potentially a predictive factor of impending joint de-
struction and surgery need, an observation needing
further studies.
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Table 1 Comparison of duration of disease and number of lower
limb prosthesis by group
RA+CPPD
(n=24)
RA alone
(n=69)
Duration of disease
(mean±SD)
12.1±2.7 7.8±1.5 NS*
Women 15±3.9 8.9±1.5 NS*
Men 8±3.1 5±1.2 NS*
Prosthesis of lower
limb
9 15 OR
2.2
NS Not significant, OR odds ratio
*By t test
Fig. 1 Severe destructive arthropathy of the femoropatellar joint in
a 75-year-old woman having a seropositive RA for 21 years. CPPD
crystals were not found until January 2003
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